Institutional Ownership
Takeda Pharmaceutical Co Ltd
CUSIP 874060205SPONSORED ADSTAKQ1 2026
13D / 13G Filings
5
Schedule 13D/13G on record
Beneficial Filers
2
Distinct reporting persons
Largest Stake
6.0%
Max % of class reported
Institutional Holders
356
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
5 filings · latest Feb 5, 2024
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 5, 2024 | Sumitomo Mitsui Trust Holdings, Inc. | 13G/A | 5.5% | 87.40M | SEC |
| 2 | Feb 3, 2023 | Sumitomo Mitsui Trust Holdings, Inc. | 13G/A | 5.9% | 93.60M | SEC |
| 3 | Feb 4, 2022 | Sumitomo Mitsui Trust Holdings, Inc. | 13G/A | 5.7% | 90.91M | SEC |
| 4 | Feb 5, 2021 | Sumitomo Mitsui Trust Holdings, Inc. | 13G | 6.0% | 94.03M | SEC |
| 5 | Feb 14, 2020 | Causeway Capital Management LLC | 13G/A | 2.6% | 40.93M | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Capital Research Global Investors | 19.10M | $353.81M |
| 2 | Fmr LLC | 7.12M | $131.82M |
| 3 | Morgan Stanley | 6.47M | $119.82M |
| 4 | Adage Capital Partners Gp, L.L.C. | 6.42M | $118.99M |
| 5 | Goldman Sachs Group Inc | 5.62M | $104.06M |
| 6 | Brandes Investment Partners, LP | 4.43M | $82.06M |
| 7 | Blackrock, Inc. | 3.18M | $58.83M |
| 8 | Arrowstreet Capital, Limited Partnership | 3.12M | $57.71M |
| 9 | Renaissance Technologies LLC | 2.99M | $55.36M |
| 10 | Ubs Group AG | 2.74M | $50.75M |